Alpha glucosidase inhibitor voglibose can prevent pioglitazone-induced body weight gain in Type 2 diabetic patients.
Mayumi
M
Negishi
Kenju
K
Shimomura
Peter
P
Proks
Yohnosuke
Y
Shimomura
Masatomo
M
Mori
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007294:Inositol / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D007294:Inositol; C102817:voglibose; D000077205:Pioglitazone